REAL WORLD MULTICENTER EXPERIENCE OF PEDIATRIC CYSTIC FIBROSIS PATIENTS STARTED ON TEZACAFTOR/IVACAFTOR plus IVACAFTOR

Pan A.; Autry E.; McKinzie C. J.

首页> 外文期刊>Pediatric Pulmonology >REAL WORLD MULTICENTER EXPERIENCE OF PEDIATRIC CYSTIC FIBROSIS PATIENTS STARTED ON TEZACAFTOR/IVACAFTOR plus IVACAFTOR

【24h】

REAL WORLD MULTICENTER EXPERIENCE OF PEDIATRIC CYSTIC FIBROSIS PATIENTS STARTED ON TEZACAFTOR/IVACAFTOR plus IVACAFTOR

机译：Real World Multicenter of Tezacaftor / Ivacaftor Plus Ivacaftor的小儿囊性纤维化患者的多中心体验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Pediatric Pulmonology》 |2019年第2期|共1页
作者
Pan A.; Autry E.; McKinzie C. J.;
展开▼
作者单位

Johns Hopkins Univ Hosp Baltimore MD 21287 USA;

UK HealthCare Lexington KY USA;

UNC Healthcare Chapel Hill NC USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. REAL WORLD MULTICENTER EXPERIENCE OF PEDIATRIC CYSTIC FIBROSIS PATIENTS STARTED ON TEZACAFTOR/IVACAFTOR plus IVACAFTOR [J] . Pan A., Autry E., McKinzie C. J. Pediatric Pulmonology . 2019,第Suppla2期

机译：Real World Multicenter of Tezacaftor / Ivacaftor Plus Ivacaftor的小儿囊性纤维化患者的多中心体验
2. EFFECTS OF TEZACAFTOR/IVACAFTOR (TEZ/IVA) TREATMENT IN PATIENTS WITH CYSTIC FIBROSIS HOMOZYGOUS FOR F508DEL-CFTR: PATIENT-REPORTED OUTCOMES IN A PHASE 3 RANDOMIZED, CONTROLLED TRIAL (EVOLVE) [J] . Yang Y., Rizio A. A., Chuang C-C, Thorax: The Journal of the British Thoracic Society . 2018,第Suppla4期

机译：Tezacafacer / Ivacafactor（TEZ / IVA）治疗对F508del-CFTR寄生术酸性纤维化患者的影响：患者报告的第3期随机，受控试验（进化）
3. EFFECTS OF TEZACAFTOR/IVACAFTOR TREATMENT IN PATIENTS WITH CYSTIC FIBROSIS AND F508DEL/F508DEL-CFTR: PATIENT-REPORTED OUTCOMES IN A PHASE 3 RANDOMIZED, CONTROLLED TRIAL [J] . Yang Y., Rizio A., Chuang C., Pediatric Pulmonology . 2018,第Suppla2期

机译：Tezacafactor / Ivacafacter治疗在囊性纤维化患者中的影响和F508DEL / F508DEL-CFTR：患者报告的第3期随机，对照试验中的结果
4. Ivacaftor induces Pseudomonas aeruginosa population proteome changes in the airways of CF patients with G551D mutations [C] . Xia Wu, Katherine B. Hisert, Jayanthi Garudathri, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：Ivacafacter诱导铜绿假单胞菌蛋白酶蛋白质组蛋白质组变化，CF患者G551D突变患者
5. The investigation of quality of life, perceived disease severity, and adherence in patients with the G551D mutation receiving Ivacaftor therapy [D] . Hathorne, Heather 2015

机译：接受IVACafacor治疗的G551D突变患者的生活质量，感知疾病严重程度和依从性的调查
6. The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy [O] . Sherstin T. Lommatzsch, Jennifer L. Taylor-Cousar 2019

机译：替扎卡夫特和依伐卡托联合治疗囊性纤维化患者：囊性纤维化治疗的临床证据和未来前景
7. Impact of Elexacaftor/Tezacaftor/Ivacaftor on Cystic Fibrosis Liver Tests in a Real-World Cohort with and Without Baseline CFLD [O] . M. Bowen, E. Sample, A.C. Collins, 2021

机译：Elexacaftor / Tezacafetor / Ivacafeaferor对现实世界队列囊性纤维化肝脏试验的影响，有没有基线CFLD

REAL WORLD MULTICENTER EXPERIENCE OF PEDIATRIC CYSTIC FIBROSIS PATIENTS STARTED ON TEZACAFTOR/IVACAFTOR plus IVACAFTOR

著录项

引文网络

相似文献

相关主题

期刊订阅